A Phase I Pilot Study Comparing 123I MIP 1072 Versus 111In Capromab Pendetide in Subjects With Metastatic Prostate Cancer
Latest Information Update: 13 Dec 2021
At a glance
- Drugs Iofolastat I-123 (Primary) ; Capromab
- Indications Prostate cancer
- Focus Diagnostic use
- Sponsors Molecular Insight Pharmaceuticals
- 15 May 2014 New trial record